Usefulness of HANBAH Score in Japanese Patients With Acute Heart Failure

• Published in: The American journal of cardiology Vol. 203; pp. 45 - 52
• Main Authors: Kaneko, Tomohiro, Kagiyama, Nobuyuki, Nakamura, Yutaka, Dotare, Taishi, Sunayama, Tsutomu, Ishiwata, Sayaki, Maeda, Daichi, Iso, Takashi, Kato, Takao, Suda, Shoko, Hiki, Masaru, Matsue, Yuya, Kasai, Takatoshi, Minamino, Tohru
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 15.09.2023; Elsevier Limited
• Subjects: Age; Anemia; Blood; Cardiac arrhythmia; Cardiovascular disease; Confidence intervals; Congestive heart failure; Creatinine; Death; Diabetes; Diabetes mellitus; Ejection fraction; Fibrillation; Heart failure; Heart rate; Hemoglobin; High density; High density lipoprotein; Hospitalization; Ischemia; Medical prognosis; Men; Mortality; Nitrogen; Population studies; Reclassification; Risk; Sodium; Urea; Ureas; Uric acid
• ISSN: 0002-9149; 1879-1913
• DOI: 10.1016/j.amjcard.2023.06.114

The HANBAH score is a novel simple risk score consisting of hemoglobin level, age, sodium (N) level, blood urea nitrogen level, atrial fibrillation, and high-density lipoprotein. We aimed to validate this score in an external population. This retrospective study included 744 patients hospitalized for acute heart failure between 2015 and 2019. Each of the following criteria was scored as 1 point: hemoglobin level (<13.0 g/L for men and <12.0 g/L for women), atrial fibrillation, age (>70 years), serum blood urea nitrogen level (>26 mg/100 ml for men and >28 mg/100 ml for women), serum high-density lipoprotein level (<25 mg/100 ml), and serum sodium level (<135 mg/100 ml). HANBAH scores were available for 736 patients (age, 75 ± 13 years; 60% male; reduced [<40%] and preserved ejection fraction [≥50%]: 35% and 49%, respectively). All-cause death during follow-up, a composite of death and heart failure rehospitalization, and in-hospital death were observed in 173, 274, and 51 patients, respectively. The HANBAH score was significantly associated with these end points after adjustment for covariates (adjusted hazard ratio 1.38 [95% confidence interval 1.16 to 1.64], p <0.001; 1.27 [1.11 to 1.45], p <0.001; and 1.66 [1.18 to 2.33], p <0.001, respectively). Receiver operating characteristic and net reclassification improvement analyses showed that the HANBAH score performed significantly better than AHEAD (atrial fibrillation, hemoglobin [anemia], elderly, abnormal renal parameters, diabetes mellitus) and AHEAD-U (AHEAD with uric acid) scores and similar to the multi-domain ACUTE HF score for all end points. In conclusion, the HANBAH score showed powerful risk stratification in this external Japanese cohort. Despite its simplicity, it performed better than other simple risk scores and similar to a multidomain risk score. [Display omitted]